홈 › 난소암 › 뉴멕시코 › Albuquerque
NM Albuquerque의 난소암 임상 시험
난소암 관련 연구 15개가 Albuquerque 및 인근(약 30마일 이내) 지역에서 참여자를 모집하고 있습니다. 연구 항목을 열어 참여 자격 및 연구 팀 연락처를 확인하세요.
공식 연구 텍스트(영어)
연구 대상자를 모집 중이신가요? 이 페이지 상단에 노출하세요 — 30일 동안 $99 →
Testing the Addition of Paclitaxel Administered Into the Abdominal Cavity Combined With Chemotherapy for Patients With Gastric Cancer Spread to the Abdominal Cavity
피험자 모집 중2/3상
- University of New Mexico Cancer Center, Albuquerque
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
피험자 모집 중2상
- University of New Mexico Cancer Center, Albuquerque
A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.
피험자 모집 중2상
- Optimum Clinical Research Group /ID# 274583, Albuquerque
Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)
피험자 모집 중2상
- Research Site, Albuquerque
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
피험자 모집 중3상
- Optimum Clinical Research Group, Albuquerque
Prospective Laboratory Study Biologic Specimens and Tumor Tissue of Patients With Cancer
피험자 모집 중관찰 연구
- University of New Mexico Cancer Center, Albuquerque
Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
피험자 모집 중3상
- Unm Comprehensive Cancer Center, Albuquerque
A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies
피험자 모집 중1/2상
- Research Site, Albuquerque
A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)
피험자 모집 중3상
- University of New Mexico Comprehensive Cancer Center ( Site 0055), Albuquerque
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
피험자 모집 중
- University of New Mexico Cancer Center, Albuquerque
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
피험자 모집 중3상
- University of New Mexico Cancer Center, Albuquerque
Clinical Pre-screening Protocol for Ovarian Cancer
피험자 모집 중관찰 연구
- University of New Mexico Comprehensive Cancer, Albuquerque
Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers
피험자 모집 중2상
- 292, Albuquerque
Heated Intraperitoneal Chemotherapy Followed by Niraparib for Ovarian, Primary Peritoneal and Fallopian Tube Cancer
피험자 모집 중3상
- University of New Mexico Comprehensive Cancer Center, Albuquerque
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
피험자 모집 중관찰 연구
- Massive Bio SYNERGY-AI site, Albuquerque
다른 도시의 난소암 시험
- Houston, TX연구 89개
- New York City, NY연구 69개
- Boston, MA연구 61개
- Los Angeles, CA연구 50개
- Nashville, TN연구 49개
- Arlington, VA연구 46개
- Philadelphia, PA연구 44개
- Columbus, OH연구 39개
- St. Louis, MO연구 38개
- Chicago, IL연구 36개
- San Antonio, TX연구 31개
- Cleveland, OH연구 30개
Albuquerque의 다른 연구
- 비소세포폐암연구 18개
- 유방암연구 17개
- 암 (전체)연구 14개
- 폐암연구 14개
- 전이성 암연구 12개
- 자궁내막암연구 12개
- 제2형 당뇨병연구 11개
- 심혈관 질환연구 10개
- 흑색종연구 9개
- 급성 골수성 백혈병연구 9개
- 전립선암연구 9개
- 만성 신장 질환연구 8개
ClinicalTrials.gov 출처, 2026. 10. 6. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.